The Trough Levels Of Bevacizumab Significantly Affect The Outcome Of The Treatment In Patients With Metastatic Colorectal Cancer: A Turkish Oncology Group Study.

Hakan Akbulut,Muge Ocal,Fatma Gizem Sonugur,Samira Abdi Abgarmi,Cansu Babahan, Busra Akay,Ulku Yalcintas Arslan,Mehmet Artac,Mehmet Ali Nahit Sendur,Ahmet Demirkazik

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 2|浏览13

暂无评分

摘要

e15553Background: We aimed to investigate the role of angiogenic factors and bevacizumab (Beva) trough levels on the efficacy of Beva plus chemotherapy combination in metastatic colorectal cancer p...

查看译文

关键词

metastatic colorectal cancer,bevacizumab,turkish oncology group study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要